Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)

Completed · Not applicable

Conditions studied: Major Depressive Disorder, Generalized Anxiety Disorder

In brief

Participants with Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD) will use a prescribed digital therapeutic for 8-10 weeks, and will complete depression and anxiety measures during this time. After the treatment period, participants will be followed monthly for 12 months.

Key facts

Study ID

NCT05016050

Run by

Happify Inc.

People needed

367

Starts

2021-08-09

Expected to finish

2023-04-14

Last updated by the study team

2023-06-01

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 22 years or older at the time of screening
• Meets DSM-5 diagnostic criteria for Major Depressive Disorder or Generalized Anxiety Disorder
• Access to and willingness to use computer equipment/smartphone compatible with the product platform over a functional network for the study duration
• Currently residing in the United States
• Key Exclusion Criteria:
• Risk of suicide or has attempted suicide within 24 months of the screening visit
• Moderate to severe substance use disorder
• Current co-morbid psychiatric diagnosis including PTSD, Schizophrenia, Bipolar Disorder I or II, or Borderline Personality Disorder
• Currently pregnant or planning to become pregnant during the treatment period
• Note: Other protocol-defined inclusion/exclusion criteria applied.

Where it is running

• Happify Health (Remote) — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.